Study: Computer Can Predict Drug Side Effects, Save Billions | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Study: Computer Can Predict Drug Side Effects, Save Billions

June 11, 2012
by Gabriel Perna
| Reprints

Recent research has determined that a set of computer models can predict the negative side effects in hundreds of current drugs, based on the similarity between their chemical structures and those molecules known to cause side effects. The conclusion was driven by researchers at the University of California at San Francisco, and will appear in a paper in the journal Nature.

Led by researchers in the UCSF School of Pharmacy, Novartis Institutes for BioMedical Research (NIBR), and SeaChange Pharmaceuticals, Inc., it looked at how a computer model could help researchers eliminate risky drug prospects by identifying which ones were most likely to have adverse side effects. The researchers focused on 656 drugs that are currently prescribed, with known safety records or side effects. They were able to predict such undesirable targets — and thus potential side effects — half of the time.

According to Brian Shoichet, PhD, a UCSF professor of pharmaceutical chemistry and joint advisor on the project alongside Laszlo Urban, MD, PhD, at Novartis, this work was the first to tackle hundreds of compounds at once. As a result, he says, it offers a possible new way for researchers to focus their efforts on developing the compounds that will be safest for patients, while potentially saving billions of dollars each year that goes into studying and developing drugs that fail.

“The biggest surprise was just how promiscuous the drugs were, with each drug hitting more than 10 percent of the targets, and how often the side-effect targets were unrelated to the previously known targets of the drugs,” Shoichet said in a statement. “That would have been hard to predict using standard scientific approaches.”

Among reasons that potential drugs fail in clinical trials, adverse drug effects are the second most common reason behind effectiveness. This can cost up to $1 billion over 15 years, the researchers say. Some drugs, recent research estimates, can cost as high as $12 billion.

“This basically gives you a computerized safety panel, so someday, when you’re deciding among hundreds of thousands of compounds to pursue, you could run a computer program to prioritize for those that may be safest,” Michael Keiser, PhD, co-first author of the paper, said in a statement.

Get the latest information on Finance and Revenues and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Community Data Sharing: Eight Recommendations From San Diego

A learning guide focuses on San Diego’s experience in building a community health information exchange and the realities of embarking on a broad community collaboration to achieve better data sharing.

HealthlinkNY’s Galanis to Step Down as CEO

Christina Galanis, who has served as president and CEO of HealthlinkNY for the past 13 years, will leave her position at the end of the year.

Email-Related Cyber Attacks a Top Concern for Providers

U.S. healthcare providers overwhelmingly rank email as the top source of a potential data breach, according to new research from email and data security company Mimecast and conducted by HIMSS Analytics.

Former Health IT Head in San Diego County Charged with Defrauding Provider out of $800K

The ex-health IT director at North County Health Services, a San Diego County-based healthcare service provider, has been charged with spearheading fraudulent operations that cost the organization $800,000.

Allscripts Touts 1 Billion API Shares in 2017

Officials from Chicago-based health IT vendor Allscripts have attested that the company has reached a new milestone— one billion application programming interface (API) data exchange transactions in 2017.

Dignity Health, CHI Merging to Form New Catholic Health System

Catholic Health Initiatives (CHI), based in Englewood, Colorado, and San Francisco-based Dignity Health officially announced they are merging and have signed a definitive agreement to combine ministries and create a new, nonprofit Catholic health system.